Maomei Ruan
Overview
Explore the profile of Maomei Ruan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
238
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lei B, Zhang H, Sun J, Wang L, Ruan M, Yan H, et al.
Clin Lung Cancer
. 2024 Nov;
26(1):18-28.e6.
PMID: 39613542
Objectives: To investigated whether the basal F-18-FDG PET/CT could evaluate the prognosis or the benefit from adjuvant chemotherapy after surgery of patients with early-stage NSCLC with visceral pleural invasion. Materials...
2.
Yan H, Wang L, Lei B, Ruan M, Chang C, Zhou M, et al.
Quant Imaging Med Surg
. 2024 Feb;
14(2):1944-1956.
PMID: 38415117
Background: Anterior mediastinal masses are relatively uncommon, and mediastinal lymphomas are the malignancies most likely to be confused with thymic epithelial tumors (TETs). The aim of this study was to...
3.
Zuo Y, Liu L, Chang C, Yan H, Wang L, Sun D, et al.
Med Phys
. 2024 Jan;
51(7):4872-4887.
PMID: 38285641
Background: Accurate, noninvasive, and reliable assessment of epidermal growth factor receptor (EGFR) mutation status and EGFR molecular subtypes is essential for treatment plan selection and individualized therapy in lung adenocarcinoma...
4.
Ruan M, Chang C, Sun J, Liu L, Wang L, Lei B, et al.
J Cancer Res Clin Oncol
. 2023 Aug;
149(16):14493-14507.
PMID: 37572120
Purpose: Our study intended to explore the correlation between HER2 alterations and F-FDG PET/CT metabolic parameters and their prognostic value in EGFR-negative non-small-cell lung cancer (NSCLC) patients detected by next-generation...
5.
Sun X, Chen T, Xie C, Liu L, Lei B, Wang L, et al.
BMJ Open
. 2022 May;
12(5):e056804.
PMID: 35580966
Objectives: Cancer cell has aberrant metabolism. The purpose of this study aimed to investigate relationships between maximum standard uptake value (SUVmax）of fluoro-2-deoxy-d-glucose and T stages, histological grades and pathological subtypes...
6.
Chang C, Ruan M, Lei B, Yu H, Zhao W, Ge Y, et al.
EJNMMI Res
. 2022 Apr;
12(1):23.
PMID: 35445899
Background: To investigate the value of F-FDG PET/CT molecular radiomics combined with a clinical model in predicting thoracic lymph node metastasis (LNM) in invasive lung adenocarcinoma (≤ 3 cm). Methods:...
7.
Tong J, Ruan M, Jin Y, Fu H, Cheng L, Luo Q, et al.
Eur Thyroid J
. 2022 Feb;
11(2).
PMID: 35195082
Poorly differentiated thyroid carcinoma (PDTC) is a rare thyroid carcinoma originating from follicular epithelial cells. No explicit consensus can be achieved to date due to sparse clinical data, potentially compromising...
8.
Liu L, Yan H, Ruan M, Yang H, Wang L, Lei B, et al.
Cancer Sci
. 2021 May;
112(8):3083-3098.
PMID: 34033176
Protein kinase B (AKT) hyperactivation and de novo lipogenesis are both common in tumor progression. Sterol regulatory element-binding protein 1 (SREBP1) is the master regulator for tumor lipid metabolism, and...
9.
Chang C, Sun X, Wang G, Yu H, Zhao W, Ge Y, et al.
Front Oncol
. 2021 Mar;
11:603882.
PMID: 33738250
Objectives: Anaplastic lymphoma kinase (ALK) rearrangement status examination has been widely used in clinic for non-small cell lung cancer (NSCLC) patients in order to find patients that can be treated...
10.
Chang C, Zhou S, Yu H, Zhao W, Ge Y, Duan S, et al.
Eur Radiol
. 2021 Feb;
31(8):6259-6268.
PMID: 33544167
Objectives: This study aims to develop a clinically practical model to predict EGFR mutation in lung adenocarcinoma patients according to radiomics signatures based on PET/CT and clinical risk factors. Methods:...